AMARIN CORP PLC\UK Restructuring Reserve
AMARIN CORP PLC\UK (AMRN) had Restructuring Reserve of $2.59 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-07-29
- 2026-06-30: Restructuring Reserve $2.59M.
- 2026-03-31: Restructuring Reserve $5.24M.
- 2025-12-31: Restructuring Reserve $7.43M.
- 2025-09-30: Restructuring Reserve $12.80M.
| Period end | Restructuring Reserve |
|---|---|
| 2026-06-30 | $2.59M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $5.24M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $7.43M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $12.80M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $20.52M 10-Q · filed 2025-07-30 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2024-09-30 | $9.90M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $10.23M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $10.71M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $13.59M 10-K · filed 2025-03-12 |
| 2023-09-30 | $29.68M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $26.45M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $2.12M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $192.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $5.95M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $22.91M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $238.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.19M 10-K · filed 2023-03-01 |
| 2021-09-30 | $13.81M 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |